Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954095 · ClinicalTrials.gov registry record
The Impact of Vaginal and IM Progestins on the Cervix
A clinical trial of Preterm Birth and Short Cervical Length, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 89
- Enrollment target
- 4
- Study locations
NCT01954095: Completed study of Preterm Birth and Short Cervical Length, sponsored by University of Pittsburgh.
NCT01954095 is a study of Preterm Birth and Short Cervical Length that has completed, run by University of Pittsburgh. The registered enrollment target is 89 participants, below the 4,407-participant average among 39 other Preterm Birth trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01954095, a study of Preterm Birth and Short Cervical Length, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to analyze how the body handles and responds to progesterone treatment in parous and nulliparous women at risk of pre-term birth.
Primary Outcome
Proteins in the cervicovaginal fluid with expression changes two-fold or greater between day 0 and week 2 of either vaginal or IM progestin therapy.
Conditions Studied
Study Locations (4)
Indiana
- Indiana University School of Medicine - Indianapolis
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Medical Branch - Galveston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-03 |
What the finished NCT01954095 record still lists
NCT01954095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 4,407-participant average among 39 other Preterm Birth trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.
NCT01954095 reports a single indexed study location in Indiana, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT01954095 about?
NCT01954095 is a clinical study titled "The Impact of Vaginal and IM Progestins on the Cervix". The purpose of this study is to analyze how the body handles and responds to progesterone treatment in parous and nulliparous women at risk of pre-term birth.
What is the current status of trial NCT01954095?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2013-08. Estimated completion is 2015-03.
What conditions does trial NCT01954095 study?
This clinical trial studies the following conditions: Preterm Birth, Short Cervical Length.
Who is sponsoring clinical trial NCT01954095?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01954095 being conducted?
This trial has 4 study locations across Indiana, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01954095's enrollment target sits among peer trials
89 27th of 39 higher than 13 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia